Phitonex, Inc., a Durham, N.C.-based developer of next generation fluorescent labels for biomarker detection on single cells, closed a $2M seed funding.
The round was led by private investors.
Led by Chris Dwyer, Ph.D. Co-Founder and CSO, and Alvin Lebeck, Ph.D, Chairman and co-founder, Phitonex is developing next generation fluorescent labels for biomarker detection. Its platform allows for the precise engineering of optical properties to provide high resolution analysis of single cells by high throughput flow cytometry.
The company intends to use the funds to scale, take its labels to market, and to expand and accelerate the development of precision molecular-scale optics for various applications in need of high resolution biology.
Phitonex will be releasing its NovaFluor test kits for multicolor staining this fall, and plans to release more labels for high resolution biology soon.